Related Experiment Video
Updated: Jul 16, 2026
07:01
Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.7K
A peer mentoring program for Chinese American dementia caregivers: a pilot randomized controlled trial
Jinyu Liu1, Ethan Siu Leung Cheung2, Yifan Lou3
1Diana R. Garland School of Social Work, Baylor University, Waco, TX, USA.
Aging & Mental Health
|May 2, 2024
Summary
A peer mentoring program effectively reduced loneliness, caregiver burden, and depressive symptoms in Chinese American dementia caregivers. This culturally sensitive intervention shows promise for improving mental health in this underserved population.
Area of Science:
- Gerontology
- Public Health
- Cultural Psychiatry
Background:
- Chinese Americans face a significant gap in culturally sensitive dementia care interventions.
- This population is one of the fastest-growing minority groups in the U.S., highlighting the need for tailored support.
Purpose of the Study:
- To develop and pilot test a peer mentoring program for Chinese American dementia caregivers.
- To assess the feasibility and preliminary efficacy of this culturally sensitive intervention.
Main Methods:
- A pilot randomized controlled trial involving 38 Chinese American caregivers in New York City.
- Measured caregiving competence, loneliness, caregiver burden, and depressive symptoms at baseline, 3-month, and 9-month follow-ups.
Main Results:
- The peer mentoring program demonstrated high feasibility with good retention and fidelity.
- The intervention group showed significant reductions in loneliness (3-month) and caregiver burden and depressive symptoms (9-month) compared to the control group.
- No significant differences were found in caregiving competence between the groups.
Conclusions:
- Empowering experienced caregivers within the Chinese American community is a feasible and potentially effective strategy for improving mental health.
- Further research with larger samples is recommended to confirm the efficacy of this peer mentoring approach.
More Related Videos
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...